ChartRow logo
ChartRow
Stocks and ETFs
ABBV
AbbVie Inc.Stock · Healthcare
$261.07+$10.01 (+3.99%)as of market close, Jul 2, 2026
CompareLLYUNHJNJMRKABTTMO

ABBV returns by year

AbbVie Inc. has returned +20.3% annually (CAGR) since 2014. Calendar-year, monthly and weekly total returns for AbbVie Inc. (ABBV) below, through July 2, 2026 — the most recent year is year-to-date.

Annualized (CAGR)
+20.3%
2014–2026
Average year
+18.9%
12 full years
Best year
+60.0%
2017
Worst year
-6.5%
2015
Positive years
9/12
75% up

AbbVie Inc. returns by year (20142026)#

Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).

AbbVie Inc. annual returns by year
YearTotal return
2026YTD
+16.1%
2025
+32.8%
2024
+18.8%
2023
-0.3%
2022
+24.0%
2021
+32.4%
2020
+27.6%
2019
+1.4%
2018
-1.0%
2017
+60.0%
2016
+9.8%
2015
-6.5%
2014
+27.9%

Total return by period

-60%-40%-20%+0%+20%+40%+60%
'14'15'16'17'18'19'20'21'22'23'24'25'26

Methodology#

Returns are total returns (dividends reinvested), computed from ABBV's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.

See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum

FAQ

What is AbbVie Inc.'s average annual return?
Since 2014, AbbVie Inc. (ABBV) has returned about 20.3% a year (the compound annual growth rate) and an average calendar-year return of 18.9%.
What were AbbVie Inc.'s best and worst years?
Over 2014–2026, the best year was 2017 (+60.0%) and the worst was 2015 (-6.5%).
How often is AbbVie Inc. up in a year?
9 of the 12 full years since 2014 were positive — about 75% of the time.